LncRNA ANRIL/miR‐125a axis exhibits potential as a biomarker for disease exacerbation, severity, and inflammation in bronchial asthma

Shenglan Ye, Shan Zhu, Lijuan Feng

Journal of Clinical Laboratory Analysis · 2019 · 32 citations · 16 references

DOIFull text

Open access

Abstract

LncRNA ANRIL/miR-125a is potentially indicative of disease exacerbation, exacerbation severity, and inflammation for bronchial asthma, while these findings are preliminary and need further confirmation.

References

16